TrialEuropean journal of applied physiology2017

Endurance, aerobic high-intensity, and repeated sprint cycling performance is unaffected by normobaric "Live High-Train Low": a double-blind placebo-controlled cross-over study.

Jacob Bejder et al.PubMed ↗Publisher ↗

No numbers read from the abstract.